Sorafenib effect on liver neoplastic changes in rats: more than a kinase inhibitor

Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there?

(2015) Yu-Yun Shao   WORLD JOURNAL OF GASTROENTEROLOGY

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells

(2015) Li Ma et al.   Oncotarget

Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner

(2015) Irina Kiprianova et al.   NEOPLASIA

Regulation of cell death receptor S-nitrosylation and apoptotic signaling by Sorafenib in hepatoblastoma cells

(2015) A. Rodríguez-Hernández et al.   Redox Biology

Clinical Impact of Chemotherapy-Related Adverse Events in Patients with Metastatic Breast Cancer in an Integrated Health Care System

(2015) Nazia Rashid et al.   Journal of Managed Care & Specialty Pharmacy

Molecular Pathways: Epigenetic Modulation of Wnt-Glycogen Synthase Kinase-3 Signaling to Target Human Cancer Stem Cells

(2014) Y. D. Benoit et al.   CLINICAL CANCER RESEARCH

Do mantle cell lymphomas have an ‘Achilles heel’?

(2014) Nakhle Saba et al.   CURRENT OPINION IN HEMATOLOGY

NF-κB in Cellular Senescence and Cancer Treatment

(2014) Hua Jing et al.   MOLECULES AND CELLS

Mesenchymal Stem Cells Promote Liver Regeneration and Prolong Survival in Small-For-Size Liver Grafts: Involvement of C-Jun N-Terminal Kinase, Cyclin D1, and NF-κB

(2014) Weijie Wang et al.   PLoS One

Downregulation of signal transducer and activator of transcription 3 by sorafenib: A novel mechanism for hepatocellular carcinoma therapy

(2014) Man-Hsin Hung   WORLD JOURNAL OF GASTROENTEROLOGY

Pomegranate Bioactive Constituents Suppress Cell Proliferation and Induce Apoptosis in an Experimental Model of Hepatocellular Carcinoma: Role of Wnt/β-Catenin Signaling Pathway

(2013) Deepak Bhatia et al.   Evidence-based Complementary and Alternative Medicine

Epidemiology of Hepatocellular Carcinoma

(2013) Sahil Mittal et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cells

(2013) W-T Tai et al.   Cell Death & Disease

Sorafenib-Induced Hepatocellular Carcinoma Cell Death Depends on Reactive Oxygen Species Production In Vitro and In Vivo

(2012) R. Coriat et al.   MOLECULAR CANCER THERAPEUTICS

Quercetin Inhibits Diethylnitrosamine-Induced Hepatic Preneoplastic Lesions in Rats

(2011) C. Gupta et al.   NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL

Loss of Metallothionein Predisposes Mice to Diethylnitrosamine-Induced Hepatocarcinogenesis by Activating NF- B Target Genes

(2010) S. Majumder et al.   CANCER RESEARCH

Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model

(2009) Yue-Fang Liu et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Sorafenib inhibits signal transducer and activator of transcription 3 signaling associated with growth arrest and apoptosis of medulloblastomas

(2008) F. Yang et al.   MOLECULAR CANCER THERAPEUTICS

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

(2008) Scott M. Wilhelm et al.   MOLECULAR CANCER THERAPEUTICS

Altered β-Catenin Accumulation in Hepatocellular Carcinomas of Diethylnitrosamine-Exposed Rhesus Macaques

(2008) Bih-Rong Wei et al.   TOXICOLOGIC PATHOLOGY